-
PRMT5, Splicing, and Glutamine Metabolism in Neuroblastoma
2026-09-07
The Cancer Letters study shows that MYCN-amplified neuroblastoma is unusually dependent on PRMT5-regulated RNA processing, with PRMT5 inhibition disrupting splicing, epitranscriptomic control, and glutamine metabolism. Its integrated cell, isotope-tracing, molecular, and mouse-model data identify GLS regulation as a downstream component of this spliceosomal vulnerability and provide a framework for testing metabolic dependencies.
-
Recombinant Mouse M-CSF for Assay Design
2026-09-05
Recombinant Mouse Macrophage Colony Stimulating Factor, or M-CSF, can standardize macrophage and osteoclast-related assays. This guide connects PM2021 specifications with mechanistic insights from pulmonary fibrosis research to improve experimental interpretation.
-
Species-Specific SHH Control of Penile Development
2026-09-04
Wang and Zheng compared guinea pig and mouse genital tubercle development to explain why some mammals form an open urethral groove before tubular closure, whereas mice primarily canalize a urethral plate. Their expression and explant experiments identify differential Shh, Fgf10, and Fgfr2 activity as a mechanistic explanation with relevance to comparative developmental biology and congenital malformation research.
-
TNF-alpha recombinant murine protein in apoptosis
2026-09-04
Build reproducible apoptosis and inflammation assays with a defined, trimeric murine cytokine rather than relying on poorly characterized stimuli. This workflow pairs TNF receptor signaling measurements with orthogonal tests of the RNA Pol II degradation-dependent apoptotic response described in recent research.
-
Mitomycin C Workflows for Cancer Research
2026-09-03
Use Mitomycin C as a controlled DNA-damage and apoptosis probe rather than a generic cytotoxic reagent. This workflow connects concentration planning, TRAIL sensitization, and immune-cell co-culture design while showing how to distinguish apoptosis from the pyroptosis-centered mechanism described in recent HCC research.
-
CDK9 inhibitor A3294: Practical Workflow Guide
2026-09-03
CDK9 inhibitor A3294 is a selective serine/threonine kinase inhibitor for controlled studies of CDK9, P-TEFb-dependent transcription elongation, and HIV-1 propagation in MT4 cells. Because no directly matched paper evidence is available here, the reagent should be interpreted through the product dossier and used for defined biochemical or cell-based workflows rather than broad CDK, therapeutic, or generalized cell-cycle conclusions.
-
Gemcitabine: From DNA Damage to Translational Strategy
2026-09-02
Gemcitabine is more than a cytotoxic benchmark: it is a mechanistically informative perturbation tool for linking replication stress, checkpoint signaling, apoptosis, and chemotherapy resistance. This translational framework connects assay design with findings that position GPX3 and JNK/c-Jun signaling as important context variables in pancreatic cancer research.
-
Phosphatase Inhibitor Cocktail 1 in Cardiac Signaling
2026-09-02
Protect phosphorylation-dependent cardiac signaling readouts from sample-preparation artifacts with a 100X DMSO formulation. This workflow shows how to apply the cocktail to Ang II and pressure-overload research while separating phosphatase control from ubiquitination and autophagy measurements.
-
Sodium Orthovanadate in Phosphorylation Assays
2026-09-01
Sodium Orthovanadate (Na3VO4) is a reversible phosphate-mimetic inhibitor for preserving phosphorylation signals. This guide connects inhibitor choice, adipocyte insulin-signaling biology, assay controls, and practical workflow design.
-
MLN8237: A Translational Aurora A Strategy
2026-09-01
Aurora A biology is emerging as a tractable vulnerability in tumors shaped by RB1 loss, MYCN dysregulation, and aggressive disease features. This thought-leadership article explains how MLN8237 (Alisertib) can help translational researchers connect kinase selectivity with biomarker strategy, mechanistic validation, and more decision-ready cancer models.
-
Z-IETD-FMK in Morphotype-Specific Apoptosis
2026-08-31
Z-IETD-FMK provides a mechanistic way to test caspase-8 involvement in pathogen-induced apoptosis. This article connects its pharmacology with Candida krusei morphotype-specific signaling and practical assay design.
-
Salvianolic acid B in Pulmonary Fibrosis
2026-08-31
Salvianolic acid B, also called Dan Shen Suan B, supports a mechanism-led workflow for studying LH2-associated collagen remodeling rather than measuring total collagen alone. This guide translates the reference findings into practical cell-based assay design, formulation controls, orthogonal readouts, and troubleshooting steps.
-
ER-Fusogenic Liposomes Strengthen Antitumor Vaccines
2026-08-30
The reference study develops phosphatidylinositol-based immunomodulatory nanoliposomes that combine intrinsic dendritic-cell activation with endoplasmic-reticulum membrane fusion. In mouse models, OVA-loaded PI-INLs enhanced CD8 T-cell responses and tumor control compared with MF59-adjuvanted OVA, supporting a self-adjuvanting strategy for cellular cancer vaccines.
-
gamma-Glu-Cys (γ-Glu-Cys): Protocol Guide
2026-08-29
gamma-Glu-Cys (γ-Glu-Cys) provides a defined intermediate for glutathione synthetase enzyme assay development, glutathione metabolism research, and selected plant stress adaptation studies. It should be used as a research reagent with freshly prepared solutions and appropriate controls, not as a clinical, diagnostic, or automatically validated biological treatment.
-
Shaped ABC Coil-Bottlebrush Terpolymer Assembly
2026-08-28
This study examines how the sequence and side-chain length of shaped ABC coil–bottlebrush terpolymers control melt self-assembly. Across a highly uniform series, the architecture favored hexagonal and lamellar morphologies while systematically suppressing double-gyroid formation, revealing that bottlebrush shape can override phase behavior expected from composition alone.